Greenwich Lifesciences (GLSI)CEO bought ~$92K
Snehal Patel, CEO at Greenwich Lifesciences, bought ~$92K of Greenwich Lifesciences shares.
- ~$92K
- Approx. value · 4,300 sh @ $21.36
- 5.6M
- Holds after · shares reported
- Traded
- Dec 31, 2025
- Filed
- Jan 5, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 31, 2025InsiderCEO purchased ~$21K of GLSI shares in the open market
- Nov 7, 2025InsiderCEO purchased ~$89K of GLSI shares in the open market
- Nov 25, 2025InsiderCEO purchased ~$39K of GLSI shares in the open market
- Dec 18, 2025InsiderCEO purchased ~$52K of GLSI shares in the open market
- Dec 30, 2025InsiderCEO purchased ~$63K of GLSI shares in the open market
- Dec 31, 2025 · this disclosureInsiderCEO purchased ~$92K of GLSI shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Greenwich Lifesciences
For Greenwich Lifesciences, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GLSI page.
Other recent filings by Snehal Patel, CEO and CFO
- SEC Form 4 at Greenwich Lifesciences (GLSI)Jul 30, 2026
- SEC Form 4 at Greenwich Lifesciences (GLSI)Jul 30, 2026
- SEC Form 4 at Greenwich Lifesciences (GLSI)Jul 29, 2026
- SEC Form 4 at Greenwich Lifesciences (GLSI)Jul 27, 2026
- SEC Form 4 at Greenwich Lifesciences (GLSI)Jul 27, 2026
The full history of Snehal Patel, CEO and CFO is on the profile page.
How this filing works
Other disclosures at Greenwich Lifesciences
- SEC Form 4Jul 30, 2026
- SEC Form 4Jul 30, 2026
- SEC Form 4Jul 29, 2026
- SEC Form 4Jul 27, 2026
- SEC Form 4Jul 27, 2026
- SEC Form 4Jan 15, 2026
Everything OQRO holds on this company is on its GLSI page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data